All stock lists
American Well Corp (AMWL)
NYSE: AMWL · Real-Time Price · USD
Healthcare · Health Information Services
13.49-0.07 (-0.55%)
Insider Score
––Not scored
AMWL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Financial Health Score
Sound
From AMWL’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $218.5M
- Net income
- -$78.1M
- Net margin
- -35.7%
Leverage20 / 20
Little or no net debt.
- Total debt
- $3.0M
- Cash
- $195.9M
- Debt / equity
- 0.01
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $264.7M
- Current liabilities
- $91.3M
- Current ratio
- 2.90
Cash generation5 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$26.4M
- Free cash flow
- -$23.6M
- FCF margin
- -10.8%
Dilution & runway16 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 16.8M
- Share growth (1y)
- 5.5%
- Cash runway
- 89 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
AMWL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 52.05 M | 54.88 M | 55.31 M | 56.29 M | 70.90 M |
| Revenue Growth (YoY) | -26.59 % | — | — | — | — |
| Cost of Revenue | 24.49 M | 26.92 M | 26.97 M | 26.78 M | 31.14 M |
| Gross Profit | 27.56 M | 27.96 M | 28.34 M | 29.51 M | 39.76 M |
| SG&A Expense | 19.75 M | 25.45 M | 31.05 M | 30.81 M | 33.67 M |
| R&D Expense | 10.35 M | 12.38 M | 13.94 M | 18.58 M | 18.24 M |
| Operating Expenses | 37.12 M | 45.39 M | 53.49 M | 58.84 M | 60.13 M |
| Operating Income | -9.56 M | -17.42 M | -25.15 M | -29.33 M | -20.38 M |
| Pretax Income | -10.17 M | -10.08 M | -25.60 M | -30.69 M | -19.53 M |
| Tax Provision | -548.00 K | 217.00 K | -626.00 K | 1.22 M | -725.00 K |
| Net Income | -9.93 M | -10.89 M | -24.92 M | -32.38 M | -19.70 M |
| EPS (Basic) | -0.59 | -0.66 | -1.52 | -2.00 | -1.24 |
| EPS (Diluted) | -0.59 | -0.66 | -1.52 | -2.00 | -1.24 |
| Shares Outstanding | 16.76 M | 16.59 M | 16.40 M | 16.21 M | 15.89 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.